4//SEC Filing
Valeant Pharmaceuticals International, Inc. 4
Accession 0000885590-13-000037
$BHCCIK 0000885590operating
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 7:56 PM ET
Size
7.5 KB
Accession
0000885590-13-000037
Insider Transaction Report
Form 4
POWER ROBERT N
Director
Transactions
- Disposition to Issuer
Deferred Share Units
2013-05-30$90.81/sh+31,202$2,833,454→ 0 totalExercise: $0.00→ Common Shares, no par value (31,202 underlying) - Disposition to Issuer
Common Stock, no par value
2013-05-30$90.81/sh−4,397$399,292→ 13,084 total
Footnotes (2)
- [F1]On May 30, 2012, upon recommendation of the Nominating and Corporate Governance Committee, the Board determined that it was in the Company's best interest to terminate the equity program of the Mandatory Share Units (other units granted prior to October 3, 2004) and to be delivered in 2013 pursuant to the plan termination rules under Code Section 409A. This number represents Mandatory Share Units disposed of for a cash payment in lieu of receiving common shares.
- [F2]This number represents common shares purchased and other equity awards that were previously reported in Table 1.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000885590
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 7:56 PM ET
- Size
- 7.5 KB